Biodesix, Inc. (BDSX)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$15.16
+2.43%
Mkt Cap $154.34M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$8.67
Range $3.00 – $20.00
Implied Upside
-42.8%
Consensus $8.67 vs current $15.16